BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 14584299)

  • 1. [The NEPHRODIAB2 randomized trial].
    Villar E; Lièvre M; Labeeuw M; Pouteil-Noble C
    Nephrologie; 2003; 24(6):317-9. PubMed ID: 14584299
    [No Abstract]   [Full Text] [Related]  

  • 2. The economic benefits of preventing end-stage renal disease in patients with type 2 diabetes mellitus.
    Postma MJ; de Zeeuw D
    Nephrol Dial Transplant; 2009 Oct; 24(10):2975-83. PubMed ID: 19605601
    [No Abstract]   [Full Text] [Related]  

  • 3. The CARI guidelines. Prevention and management of chronic kidney disease in type 2 diabetes.
    Chadban S; Howell M; Twigg S; Thomas M; Jerums G; Cass A; Campbell D; Nicholls K; Tong A; Mangos G; Stack A; MacIsaac RJ; Girgis S; Colagiuri R; Colagiuri S; Craig J;
    Nephrology (Carlton); 2010 Apr; 15 Suppl 1():S162-94. PubMed ID: 20591029
    [No Abstract]   [Full Text] [Related]  

  • 4. Diabetic kidney disease: act now or pay later.
    Atkins RC; Zimmet P
    J Hypertens; 2010 Feb; 28(2):408-10. PubMed ID: 20087106
    [No Abstract]   [Full Text] [Related]  

  • 5. Diabetic kidney disease: act now or pay later.
    Atkins RC; Zimmet P
    Acta Diabetol; 2010 Mar; 47(1):1-4. PubMed ID: 20099002
    [No Abstract]   [Full Text] [Related]  

  • 6. Microalbuminuria and mortality in type 2 diabetes.
    Strayer SM
    J Fam Pract; 1998 Aug; 47(2):89-90. PubMed ID: 9722786
    [No Abstract]   [Full Text] [Related]  

  • 7. [Angiotensin II antagonist also protects the kidneys. 2 dialysis-free years for diabetics].
    MMW Fortschr Med; 2001 Oct; 143(43):50. PubMed ID: 11715881
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention and treatment of diabetic renal disease in type 2 diabetes: the BENEDICT study.
    Remuzzi G; Macia M; Ruggenenti P
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S90-7. PubMed ID: 16565256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Low carbohydrate diet slowed down the progression of renal insufficiency in type 2 diabetes. A case--difficult to draw conclusions].
    Vesti-Nielsen J; Westerlund P; Bygren P
    Lakartidningen; 2008 Jul 23-Aug 5; 105(30-31):2094-7. PubMed ID: 18751447
    [No Abstract]   [Full Text] [Related]  

  • 10. Diabetic nephropathy: what are the diabetologist's expectations?
    Passa P
    Diabetes Metab; 2000 Jul; 26 Suppl 4():6. PubMed ID: 10922967
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiovascular disease, chronic kidney disease, and type 2 diabetes mellitus: proceeding with caution at a dangerous intersection.
    Kanda T; Wakino S; Hayashi K; Plutzky J
    J Am Soc Nephrol; 2008 Jan; 19(1):4-7. PubMed ID: 18178795
    [No Abstract]   [Full Text] [Related]  

  • 12. [Increasing number of dialysis-requiring patients with diabetic nephropathies. Better diabetes control and antihypertensive treatment can counteract the trend].
    Kurkus J; Schön S; Prütz KG; Torffvit O
    Lakartidningen; 2005 May 2-15; 102(18-19):1420-3. PubMed ID: 15929425
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of insulin and oral hypoglycemic medications in patients with diabetes mellitus and advanced kidney disease.
    Snyder RW; Berns JS
    Semin Dial; 2004; 17(5):365-70. PubMed ID: 15461745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L; Kocks MJ; Laverman GD; Navis G
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Losartan in diabetic nephropathy.
    Perico N; Ruggenenti P; Remuzzi G
    Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):473-83. PubMed ID: 15225108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of renin-angiotensin-aldosterone system-based therapy in diabetes prevention and cardiovascular and renal protection.
    Abuissa H; O'Keefe J
    Diabetes Obes Metab; 2008 Dec; 10(12):1157-66. PubMed ID: 18494810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-receptor blockade in renal disease: the hard issues.
    Sica DA
    Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):469-71. PubMed ID: 15225107
    [No Abstract]   [Full Text] [Related]  

  • 18. Type 2 diabetic nephropathy: never too early to treat?
    Hilgers KF; Veelken R
    J Am Soc Nephrol; 2005 Mar; 16(3):574-5. PubMed ID: 15703269
    [No Abstract]   [Full Text] [Related]  

  • 19. Adequate protein dietary restriction in diabetic and nondiabetic patients with chronic renal failure.
    Meloni C; Tatangelo P; Cipriani S; Rossi V; Suraci C; Tozzo C; Rossini B; Cecilia A; Di Franco D; Straccialano E; Casciani CU
    J Ren Nutr; 2004 Oct; 14(4):208-13. PubMed ID: 15483780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of structured care by a pharmacist-diabetes specialist team in patients with type 2 diabetic nephropathy.
    Leung WY; So WY; Tong PC; Chan NN; Chan JC
    Am J Med; 2005 Dec; 118(12):1414. PubMed ID: 16378791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.